Back to companies

Inventiva SA: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

Inventiva SA (Inventiva) is a biopharmaceutical company The company discovers and develops therapies for fibrosis, oncology and lysosomal storage disorders. Its pipeline products include lanifibranor for non-alcoholic steatohepatitis, odiparcil for mucopolysaccharidosis, ABBV-157 for moderate to severe psoriasis, hippo for non-small cell lung Cancer and mesothelioma, and GEV for idiopathic pulmonary fibrosis. It develops compounds that target nuclear receptors, transcription factors and epigenetic modulation. The company has two innovative clinical programs, NATIVE and IMPROVES. It conducts its drug discovery research and development in partnership with various medical organizations such as AbbVie, Abbott, Solvay, and Fournier. Inventiva is headquartered in Daix, France.

 Gain a 360-degree view of Inventiva SA and make more informed decisions for your business Gain a 360-degree view of Inventiva SA and make more informed decisions for your business Contact Us
Headquarters France
Address 50 Rue De Dijon, Daix, Bourgogne, 21121
Website inventivapharma.com
Telephone 33 3 80447500
No of Employees 112
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange IVA (EPA)
Revenue (2022) $18.9M 43.5% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -103.5% (2022 vs 2021)
Market Cap* $194.4M
Net Profit Margin (2022) XYZ -41.8% (2022 vs 2021)
* As of and is in US$
View Inventiva SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Products and Services

Products
Pipeline
Lanifibranor:
NASH
XYZ
XYZ
XYZ
Understand Inventiva SA portfolio and identify potential areas for collaboration Understand Inventiva SA portfolio and identify potential areas for collaboration Contact Us
Image for loader

Competitor Comparison

Key Parameters Inventiva SA Sanofi Innate Pharma SA NGM Biopharmaceuticals Inc AB Science SA
Headquarters France France France United States of America France
City Daix Paris Marseille South San Francisco Paris
State/Province Bourgogne Ile-de-France Bourgogne California Ile-de-France
No. of Employees 112 87,994 179 138 89
Entity Type Public Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Frederic Cren Founder; Chief Executive Officer; Chairman Executive Board 2016 -
Pierre Broqua Deputy chief Executive officer; Director; Chief Scientific Officer Executive Board 2016 -
Jean Volatier Chief Financial Officer Senior Management 2012 -
Alice Roudot-Ketelers Chief Operating Officer Senior Management - -
Michael Cooreman Chief Medical Officer Senior Management 2020 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Inventiva SA key executives to enhance your sales strategy Gain insight into Inventiva SA key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer